NCAM1 and nasopharyngeal carcinoma: Prior investigations have highlighted the favourable impact of higher peripheral blood levels of CD3+/CD8+ cells and lower levels of CD3−/CD56+ cells on OS in patients with nasopharyngeal carcinoma.26